轻症抑郁患者在团体认知行为治疗后特质应对方式的变化

目的 探讨轻症抑郁患者在团体认知行为治疗后特质应对方式的改善及特质应对方式对团体认知行为治疗的影响.方法 采用前瞻性自身对照设计,对轻症抑郁患者在治疗前后,以及随访期的抑郁症状、焦虑症状和特质应对方式进行比较.结果 共纳入102例患者.与基线时比较,患者的抑郁症状、焦虑症状和特质应对方式在团体认知行为治疗结束后及随访的各个时期均有显著改善(P<0.05).Logistic回归分析显示,基线焦虑症状、消极应对方式及出勤率进入回归方程.结论 团体认知行为治疗能够改善轻症抑郁患者的抑郁焦虑症状及特质应对方式,且能够维持相对较长的时间.基线焦虑症状、消极应对方式及出勤率对团体认知行为治疗有显著影响.     

网络结构式团体认知行为治疗对轻症抑郁患者的特质应对方式和情感气质特征的影响

目的:探讨网络结构式团体认知行为治疗对轻症抑郁患者的特质应对方式、情感气质特征上的影响。方法:采用随机对照设计,符合入组条件的轻症抑郁患者被分成线上组和线下组,并进行手册式团体认知行为治疗3个月,采用特质应对方式问卷、情感气质自评量表简版在基线、治疗结束(12周末)和随访期(24周末)对患者进行评估。结果:共筛查256名被试,纳入119例轻症抑郁患者。线上组73例,线下组46例。各时间点评估结果显示,在特质应对方式,情感气质特征方面,线上组和线下组组内差异均无统计学意义。其中积极应对方式、循环气质、焦虑气质在不同时间的主效应显著且交互作用显著(P0.05或P0.01)。结论:网络结构式团体认知行为治疗对轻症抑郁患者的特质应对方式、情感气质特征与面对面的团体认知行为治疗效果差异无统计学意义,能够对轻症抑郁患者一些心理层面的改变起到一定作用。     

结构式团体认知行为治疗对轻症抑郁患者社会功能及生活质量的影响

目的:评估结构式团体认知行为治疗对轻症抑郁症患者社会功能及生活质量的影响。方法:采用前后对照设计,对102例轻症抑郁症患者每周1次、每次90 min、共12次的结构式团体认知行为治疗;并于治疗前、治疗第12、24、36和48周末随访时进行汉密尔顿抑郁量表(HAMD-17)、6项生活质量问卷(SF-6)及大体功能评定量表(GAF)评估患者抑郁症状、社会功能和生活质量。结果:共有77例完成24周随访,59例完成36周随访,49例完成48周的随访。与治疗前比较,治疗后第12周HAMD-17评分明显下降,SF-6及GAF评分明显提高(P0.05或P0.01);且这种改变在随访的24、36和48周末仍持续存在。结论:结构式团体认知行为治疗可以有效改善轻症抑郁症患者的抑郁症状、社会功能及生活质量。     

早年情感创伤对轻症抑郁患者团体认知行为治疗效果的影响

目的 探讨早年情感创伤经历在轻症抑郁患者接受团体认知行为治疗时对疗效的影响.方法 纳入102例轻症抑郁患者,在常规治疗基础上,按照统一的结构式团体认知行为治疗手册进行治疗,使用早年创伤问卷简表评估早年创伤情况,用汉密尔顿抑郁量表(HAMD-17)得分作为主要疗效指标,分别在基线,治疗4周、8周、12周,随访24周、36周、48周进行评估.根据情感创伤中位数将情感创伤分为高情感创伤组和低情感创伤组,对两组患者的治疗效果进行比较.结果 12周治疗结束时,高情感创伤组和低情感创伤组的轻症抑郁患者抑郁症状均达到临床治愈标准,且治疗效果一直持续到随访48周末.早年情感创伤组间效应不显著(F=1.36,P=0.247),交互效应显著(F=3.72,P<0.05).简单效应分析显示,两组患者接受团体认知行为治疗后,抑郁均改善明显(高情感创伤组:F=77.98,P<0.01;低情感创伤组:F=22.45,P<0.01).两组患者改善速度差异无统计学意义(t=1.19,P=0.237),但是4周末时,低情感创伤组患者抑郁得分下降更快,与高情感创伤组比较差异有统计学意义(t=-2.54,P=0.013).结论 无论情感创伤的程度如何,轻症抑郁患者接受团体认知行为治疗之后,抑郁症状显著改善且效果较持久.但在症状改善初期,高情感创伤组的改善速度较慢.     

线上结构式团体认知行为治疗对轻症抑郁患者的有效性和可行性探索

目的探讨线上结构式团体认知行为治疗(internet-based structured group cognitive behavior therapy,I-GCBT)对轻症抑郁患者的有效性和可行性。方法使用SPSS20.0软件生成随机表,将96例轻症抑郁患者分配到线上视频团体干预组(线上组,n=64)与面对面干预组(线下组,n=32),使用HAMD17、HAMA、功能大体评定量表(Global Assessment of Functioning Scale,GAF)以及抑郁症状快速检查-自我报告评分16项(16 Items Quick Inventory of Depressive Symptomatology-Self Report,QIDS-SR16)分别在基线、4周末、8周末和12周末评估患者抑郁、焦虑及整体功能水平。采用重复测量方差分析比较两组治疗效果差异,采用卡方检验比较两组脱落率、治愈率、治疗接受度差异。结果(1)2组患者基线HAMA评分差异有统计学意义(t=-2.08,P=0.04),其他基线数据差异无统计学意义。(2)对患者在组别和时间的交互作用分析显示,HAMD17、HAMA和QIDS-SR16的时间与组别交互作用均不显著(F=0.69,P>0.05;F=0.95,P>0.05;F=0.64,P>0.05),GAF的时间与组别交互作用显著(F=4.09,P<0.01),2组患者在各量表上时间主效应均显著(HAMD17:F=32.81,P<0.01;HAMA:F=20.86,P<0.01;GAF:F=105.98;P<0.01;QIDS-SR16:F=25.27,P<0.01)。12周末临床治愈率达62%(43/69),线上组57%(25/44),线下组72%(18/25),差异无统计学意义(χ^2=1.57,P=0.21)。(3)治疗期间总体脱落率为26%(21/81),线上组29%(15/51),线下组20%(6/30),2组比较差异无统计学意义(χ^2=0.87,P=0.35),患者对方案的接受程度达97%(58/60),线上组97%(35/36),线下组96%(23/24),2组比较差异无统计学意义(χ^2=0.09,P=0.78)。结论线上结构式团体认知行为治疗对轻症抑郁患者的疗效与面对面干预组相当,患者依从性较好。     

团体整合心理治疗对老年抑郁症患者临床疗效研究（英文）

背景:相关研究表明团体认知行为治疗对抑郁症患者确有疗效,但存在较高脱落率的问题,本研究在于探讨团体整合心理治疗模式,在保证疗效的基础上,为减少脱落率提供新的方法。目的 :探讨团体整合心理疗法对老年抑郁症的临床疗效影响。方法 :将100例老年抑郁症患者随机分为研究组(n=50)和对照组(n=50),研究组给予常规药物治疗联合团体整合心理治疗,对照组给予常规药物治疗联合团体认知行为治疗。两组分别在治疗前、治疗2周、4周、8周末采用汉密尔顿抑郁量表(HAMD-24)及老年抑郁量表(GDS-15)进行评分。结果 :组内比较,两组治疗后的HAMD总分和GDS总分均低于治疗前,且差异具有统计学意义(F=102.50,p=0.001;F=55.94, p0.001);组间比较,两组的HAMD总分在治疗后4周、8周末比较差异均有统计学意义(F=3.82,p=0.021);两组的GDS总分在治疗后2周、4周、8周比较异常均有统计学意义(F=4.49,p=0.009);研究组脱落7例,对照组脱落16例,脱落率差异有统计学意义(x~2=4.57, p=0.032)。结论 :药物治疗联合团体整合心理疗法可显著提高老年抑郁症患者临床疗效,改善患者治疗依从性,减少治疗脱落率。     

轻症抑郁患者团体认知行为治疗效果的相关因素分析

目的:探讨轻症抑郁(轻性抑郁障碍、恶劣心境以及轻度抑郁症)患者团体认知行为治疗效果的影响因素。方法:采用前瞻性对照设计,将89例轻症抑郁患者在团体认知行为治疗结束后汉密尔顿抑郁量表(HAMD-17)评分7分列为临床治愈组(n=58例),≥7分列为非临床治愈组(n=31例),采用HAMD-17、汉密尔顿焦虑量表(HAMA)、情感气质自评量表简版(TEMPS-A)评估两组患者临床特征及情感气质类型并进行比较。结果:临床治愈组与非临床治愈组在基线抑郁症状(t=-2.783,P=0.007)、焦虑症状(t=-3.707,P=0.000)和TEMPS-A的循环气质类型(t=-2.470,P=0.016)评分上差异有统计学意义。Logistics回归分析显示,循环气质(B=0.157,Wals=3.872,P=0.049)、基线焦虑症状(B=0.162,Wals=8.659,P=0.003)进入回归方程。结论:情感气质类型中的循环气质和基线焦虑症状可作为影响团体认知行为治疗疗效的预测因素;而诊断类型不同不影响团体认知行为治疗疗效。     

团体认知行为治疗对双相障碍患者病耻感和服药依从性的影响

目的 探究团体认知行为治疗对双相障碍患者病耻感和服药依从性的影响.方法25例患者根据配对设计分为研究组16例和对照组9例,研究组在常规治疗基础上接受团体认知行为治疗,对照组接受常规治疗,采用精神疾病病耻感量表(ISMI)和药物依从性评价量表(MARS)测评病耻感和服药依从性.结果10次治疗后,两组患者病耻感组间比较,研究组较对照组刻板印象的认可因子改善明显,差异有统计学意义(P<0.05);组内比较,研究组疏远因子、刻板印象的认可因子、歧视经历因子和病耻感总分优于治疗前,差异有统计学意义(P<0.05),而对照组总分及各因子分治疗前后比较差异均无统计学意义(P>0.05).两组患者服药依从性组间比较,两组治疗前后差异均无统计学意义(P>0.05);组内比较,研究组服药依从性优于治疗前,差异有统计学意义(P<0.05),而对照组差异无统计学意义(P>0.05).结论团体认知行为治疗可降低双相障碍患者的病耻感,提高服药依从性,对促进疾病的康复具有重要意义.     

团体认知行为治疗对复发性抑郁障碍患者自尊的影响

目的研究团体认知行为治疗对复发性抑郁障碍患者自尊水平的影响。方法将68例服用舍曲林的复发性抑郁障碍患者随机分为2组各34例,实验组并用为期8周的团体认知行为治疗。治疗前后分别使用抑郁自评量表(SDS)、缺陷感量表(FIS)和副反应量表(TESS)进行评定。结果 2组治疗结束后患者抑郁情绪均改善,但实验组改善更明显,SDS评分有显著差异(P0.05);而自尊水平提高,实验组在缺陷感量表的总量表分值和分量表中自尊、社交自信和学习能力分值增加更为显著(P0.01)。结论团体认知行为治疗合并抗抑郁药可更好提高复发性抑郁障碍患者的自尊水平,更有效改善患者的抑郁症状。     

团体认知行为治疗改善慢性病患者抑郁与焦虑水平的效果评价

目的 探讨团体认知行为治疗对伴发抑郁、焦虑的慢性病患者的干预效果。方法 按照社区随机分组。对照组接受为期8周的常规健康教育,干预组额外开展每周1次的团体认知行为干预。前后采用病人健康问卷抑郁量表（PHQ-9）、广泛性焦虑量表（GAD-7）、简明健康状况调查问卷第二版（SF-36v2）评估。结果 重复测量方差分析显示,干预后两组抑郁和焦虑量表得分降低差异显著,存在时间×组别交互作用。结论 团体认知行为治疗有助于改善慢性病患者的抑郁、焦虑情绪。仍建议结合不同慢性病人群的心理特点设计具有针对性的团体心理干预举措。     

Integration of cognitive behavioral therapy into psychiatric rehabilitation day programming

Cognitive Behavioral Therapy has substantial empirical support for the treatment of people with severe and persistent mental illnesses. Efforts to integrate this type of therapy into psychiatric rehabilitation practices are growing. This paper describes an innovative integration of Cognitive Behavioral Therapy into a psychiatric rehabilitation day program attended by people with severe and persistent mental illnesses and frequently co-occurring substance use disorders. The challenges of maintaining the cognitive model and other core features of Cognitive Behavioral Therapy in a heterogeneous, large, group-based program are discussed.     

Behavioral activation as an alternative treatment approach for Latinos with depression

Depression is one of the most commonly diagnosed psychological health problems and a major cause of disability in this country. Very little attention, however, has been given to depression among Latinos. To address this issue, the authors provide a review of the literature on psychosocial factors that contribute to depression within the Latino adult population. In addition, the authors argue that Behavioral Activation (BA), as an alternative treatment approach, may be as effective as, if not more effective than, Cognitive Behavioral Therapy because of BA's focus on environmental conditions and behavior change rather than beliefs and underlying attitudes. More importantly, components of BA can be easily adapted to accommodate specific Latino cultural values. Its application is illustrated in a case example. (PsycINFO Database Record (c) 2010 APA, all rights reserved).     

Cognitive behavioural psychotherapy: a comparison between younger and older adults in two inner city mental health teams

There is little evidence about the efficacy of Cognitive Behavioural Therapy (CBT) in the older adult population. Research highlights that the preferred treatment for this group appears to be medication. This study compares an older adult mental health service with a younger adult service in terms of range of referrals, outcomes, attendance rates and length of time in therapy. The range of disorders referred was a wide mix of anxiety disorders and depression. There were no significant differences in therapy outcomes apart from home adjustment measures where older adults showed greater improvement. Younger adults showed significantly higher rates of non- attendance (DNA) and had higher dropout rates. Possible reasons for this are discussed. CBT appeared effective in both age groups, however older adults were treated more quickly due to a higher attendance rate.     

Cognitive and Cognitive-Behavioral Therapy for substance abuse disorders

This article describes the current status of Cognitive and Behavioral Therapy as well Relapse Prevention and Coping Skill approaches applied in drug abuse treatments. The objective is show a review about theories and technique used by Cognitive Therapy and others approaches derived that, specifically Relapse Prevention and Coping Skill Treatments. Cognitive and Behavioral Therapy, Coping Skill, and Relapse Prevention are a short-time, goal-oriented and structured treatments. Thus, they assume a posture directive and active. We pointed out some difference between the theories about Cognitive Therapy, Relapse Prevention and Coping Skill. The Cognitive Therapy accentuated the focus in patients thought, feeling and circumstances that get in a dysfunctional behavioral. Relapse Prevention and Coping Skill are based in behavioral theories besides of the Cognitive. We, finally, look forward to introduce the lasted scientific finding to helpful the general psychiatric to improve the assistance in drug abuse treatment.     

Development of a Patient-Report Measure of Psychotherapy for Depression

Despite clear indications of need to improve depression treatment, practical tools that efficiently measure psychotherapy are not available. We developed a patient-report measure of psychotherapy for depression that assesses Cognitive Behavioral (CBT), Interpersonal (IPT), and Psychodynamic therapies. 420 patients with depression from a large managed behavioral health care organization completed the measure. The three subscales measuring CBT, IPT, and Psychodynamic Therapy showed good internal consistency, appropriate item-total correlations, and were supported by a 3-factor structure. Our results suggest that a patient questionnaire is a promising approach for assessing psychotherapy in quality improvement interventions.     

Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized controlled trial

Background

Previous research has shown that Short Psychodynamic Supportive Psychotherapy (SPSP) is an effective alternative to pharmacotherapy and combined treatment (SPSP and pharmacotherapy) in the treatment of depressed outpatients. The question remains, however, how Short Psychodynamic Supportive Psychotherapy compares with other established psychotherapy methods. The present study compares Short Psychodynamic Supportive Psychotherapy to the evidence-based Cognitive Behavioral Therapy in terms of acceptability, feasibility, and efficacy in the outpatient treatment of depression. Moreover, this study aims to identify clinical predictors that can distinguish patients who may benefit from either of these treatments in particular. This article outlines the study protocol. The results of the study, which is being currently carried out, will be presented as soon as they are available.

Methods/Design

Adult outpatients with a main diagnosis of major depressive disorder or depressive disorder not otherwise specified according to DSM-IV criteria and mild to severe depressive symptoms (Hamilton Depression Rating Scale score ≥ 14) are randomly allocated to Short Psychodynamic Supportive Psychotherapy or Cognitive Behavioral Therapy. Both treatments are individual psychotherapies consisting of 16 sessions within 22 weeks. Assessments take place at baseline (week 0), during the treatment period (week 5 and 10) and at treatment termination (week 22). In addition, a follow-up assessment takes place one year after treatment start (week 52). Primary outcome measures are the number of patients refusing treatment (acceptability); the number of patients terminating treatment prematurely (feasibility); and the severity of depressive symptoms (efficacy) according to an independent rater, the clinician and the patient. Secondary outcome measures include general psychopathology, general psychotherapy outcome, pain, health-related quality of life, and cost-effectiveness. Clinical predictors of treatment outcome include demographic variables, psychiatric symptoms, cognitive and psychological patient characteristics and the quality of the therapeutic relationship.

Discussion

This study evaluates Short Psychodynamic Supportive Psychotherapy as a treatment for depressed outpatients by comparing it to the established evidence-based treatment Cognitive Behavioral Therapy. Specific strengths of this study include its strong external validity and the clinical relevance of its research aims. Limitations of the study are discussed.

Trial registration

Current Controlled Trails ISRCTN31263312     

Rumination and behavioural factors in Parkinson's disease depression

ObjectiveParkinson's disease is associated with high rates of depression. There is growing interest in non-pharmacological management including psychological approaches such as Cognitive Behaviour Therapy. To date, little research has investigated whether processes that underpin cognitive models of depression, on which such treatment is based, apply in patients with Parkinson's disease. The study aimed to investigate the contribution of core psychological factors to the presence and degree of depressive symptoms.Methods104 participants completed questionnaires measuring mood, motor disability and core psychological variables, including maladaptive assumptions, rumination, cognitive-behavioural avoidance, illness representations and cognitive-behavioural responses to symptoms.ResultsRegression analyses revealed that a small number of psychological factors accounted for the majority of depression variance, over and above that explained by overall disability. Participants reporting high levels of rumination, avoidance and symptom focusing experienced more severe depressive symptoms. In contrast, pervasive negative dysfunctional beliefs did not independently contribute to depression variance.ConclusionSpecific cognitive (rumination and symptom focusing) and behavioural (avoidance) processes may be key psychological markers of depression in Parkinson's disease and therefore offer important targets for tailored psychological interventions.     

Mindfulness-Action Based Cognitive Behavioral Therapy for concurrent Binge Eating Disorder and Substance Use Disorders

Individuals with Binge Eating Disorder (BED) often evidence comorbid Substance Use Disorders (SUD), resulting in poor outcome. This study is the first to examine treatment outcome for this concurrent disordered population. In this pilot study, 38 individuals diagnosed with BED and SUD participated in a 16-week group Mindfulness-Action Based Cognitive Behavioral Therapy (MACBT). Participants significantly improved on measures of objective binge eating episodes; disordered eating attitudes; alcohol and drug addiction severity; and depression. Taken together, MACBT appears to hold promise in treating individuals with co-existing BED-SUD.     

Residual sleep beliefs and sleep disturbance following Cognitive Behavioral Therapy for major depression

Background: Sleep disturbance is a commonly reported residual symptom after effective depression treatment. This residual sleep impairment, as well as the presence of problem levels of certain sleep beliefs, may be important for depressive relapse prevention, and as such should be addressed in treatment. The following study examined residual sleep disturbance and residual maladaptive sleep beliefs in those treated with Cognitive Behavior Therapy for depression. Methods: Participants (N = 24) were clinic patients seeking treatment for depression at a community clinic. Repeated measures analyses of variance tested pre‐ to posttreatment change on depression symptoms, general negative beliefs, sleep quality, and maladaptive sleep beliefs. Results: As expected, significant time effects were found for depressive symptoms and general negative beliefs. Sleep quality scores also decreased significantly at posttreatment; however, 92% of those no longer meeting depressive criteria continued to endorse residual sleep disturbance, according to an established clinical cutoff score of >5 on a validated measure of sleep quality (the Pittsburgh Sleep Quality Index). There were no significant pre‐ to posttreatment changes for maladaptive sleep beliefs. Conclusions: The results indicate that sleep disturbance and maladaptive sleep‐related beliefs remain a problematic residual symptom of remitted depression. These findings are discussed with reference to improving cognitive behavioral treatments for depression in order to help reduce rates of residual sleep problems. Depression and Anxiety, 2011. © 2011 Wiley‐Liss, Inc.